Terms: = Germ cell tumor AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
23 results:
1. CD133 significance in glioblastoma development: in silico and in vitro study.
Abdoli Shadbad M; Nejadi Orang F; Baradaran B
Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
[TBL] [Abstract] [Full Text] [Related]
2. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
3. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-raf-1-ELK3 signaling pathway.
Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):972-981. PubMed ID: 35737446
[TBL] [Abstract] [Full Text] [Related]
4. Infantile metastatic ependymoma with a novel molecular profile and favorable outcome to intensive chemotherapy without irradiation: Case-based review.
De Faria FW; Schieffer KM; Pierson CR; Boue DR; LaHaye S; Miller KE; Amayiri N; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly B; White P; Magrini V; Wilson RK; Mardis ER; Cottrell CE; Rusin J; Finlay JL; Osorio DS
Genes Chromosomes Cancer; 2023 Jan; 62(1):39-46. PubMed ID: 35716171
[TBL] [Abstract] [Full Text] [Related]
5. Oncogenic Fusions in Gliomas: An Institutional Experience.
Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
[TBL] [Abstract] [Full Text] [Related]
6. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract] [Full Text] [Related]
7. Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.
Mahapatra L; Andruska N; Mao C; Gruber SB; Johnson TM; Fullen DR; Raskin L; Shapiro DJ
Melanoma Res; 2019 Oct; 29(5):539-543. PubMed ID: 30543563
[TBL] [Abstract] [Full Text] [Related]
8. Spinal Pleomorphic Xanthoastrocytoma With a QKI-raf1 Fusion.
Daoud EV; Wachsmann M; Richardson TE; Mella D; Pan E; Schwarzbach A; Oliver D; Hatanpaa KJ
J Neuropathol Exp Neurol; 2019 Jan; 78(1):10-14. PubMed ID: 30517658
[TBL] [Abstract] [Full Text] [Related]
9. A Comparative Evaluation of the Cytotoxic and Antioxidant Activity of
Turkez H; Tozlu OO; Lima TC; de Brito AEM; de Sousa DP
Oxid Med Cell Longev; 2018; 2018():2083923. PubMed ID: 30057673
[TBL] [Abstract] [Full Text] [Related]
10. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Phillips JJ; Gong H; Chen K; Joseph NM; van Ziffle J; Bastian BC; Grenert JP; Kline CN; Mueller S; Banerjee A; Nicolaides T; Gupta N; Berger MS; Lee HS; Pekmezci M; Tihan T; Bollen AW; Perry A; Shieh JTC; Solomon DA
Brain Pathol; 2019 Jan; 29(1):85-96. PubMed ID: 30051528
[TBL] [Abstract] [Full Text] [Related]
11. miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/raf1 axis.
Chai Z; Fan H; Li Y; Song L; Jin X; Yu J; Li Y; Ma C; Zhou R
Oncol Rep; 2017 Nov; 38(5):2717-2726. PubMed ID: 29048686
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies.
Bae JM; Choi YY; Kim DS; Lee JH; Jang HS; Lee JH; Kim H; Oh BH; Roh MR; Nam KA; Chung KY
J Am Acad Dermatol; 2015 Jan; 72(1):59-70. PubMed ID: 25440435
[TBL] [Abstract] [Full Text] [Related]
14. Expression of Raf Kinase Inhibitor Protein (RKIP) is a predictor of uveal melanoma metastasis.
Caltabiano R; Puzzo L; Barresi V; Cardile V; Loreto C; Ragusa M; Russo A; Reibaldi M; Longo A
Histol Histopathol; 2014 Oct; 29(10):1325-34. PubMed ID: 24763848
[TBL] [Abstract] [Full Text] [Related]
15. Sorafenib tosylate as a radiosensitizer in malignant astrocytoma.
Sherman JH; Kirzner J; Siu A; Amos S; Hussaini IM
J Clin Neurosci; 2014 Jan; 21(1):131-6. PubMed ID: 24139873
[TBL] [Abstract] [Full Text] [Related]
16. MAP kinase signaling and inhibition in melanoma.
Sullivan RJ; Flaherty K
Oncogene; 2013 May; 32(19):2373-9. PubMed ID: 22945644
[TBL] [Abstract] [Full Text] [Related]
17. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract] [Full Text] [Related]
18. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy.
Su DM; Zhang Q; Wang X; He P; Zhu YJ; Zhao J; Rennert OM; Su YA
Mol Cancer Ther; 2009 May; 8(5):1292-304. PubMed ID: 19383853
[TBL] [Abstract] [Full Text] [Related]
19. RAF expression in human astrocytic tumors.
Hagemann C; Gloger J; Anacker J; Said HM; Gerngras S; Kühnel S; Meyer C; Rapp UR; Kämmerer U; Vordermark D; Flentje M; Roosen K; Vince GH
Int J Mol Med; 2009 Jan; 23(1):17-31. PubMed ID: 19082503
[TBL] [Abstract] [Full Text] [Related]
20. The role of B-RAF in melanoma.
Gray-Schopfer VC; da Rocha Dias S; Marais R
Cancer Metastasis Rev; 2005 Jan; 24(1):165-83. PubMed ID: 15785879
[TBL] [Abstract] [Full Text] [Related]
[Next]
